Dr. Winston Chan is a double board-certified General Surgeon and Colon and Rectal Surgeon with additional certification and training in the use of the Da Vinci Xi robotic system for minimally invasive surgeries. He is an accomplished surgeon with extensive experience in both university-based teaching and clinical robotics proctoring.Dr. Chan earned his medical degree from the University of Cincinnati College of Medicine. He completed his general surgery residency at The University of Texas Health Science Center at Houston and his colon and rectal surgery fellowship at Baylor University Medical Center in Dallas. Dr. Chan's passion lies in using the latest advanced medical technology, such as robotics and laparoscopy, in combination with his own surgical dexterity to treat complex diseases through small incisions to promote patient comfort and outcomes. His surgical expertise includes treatment of gallbladder disease, hernias, colorectal cancer, diverticulitis and inflammatory bowel disease, anorectal disease, reflux disorders, and soft tissue conditions. Outside of work, he enjoys snowboarding, scuba diving, traveling and spending time with family.Dr. Chan is a member of the American College of Surgeons, American Society of Colon and Rectal Surgeons, and Tarrant County Medical Society. He speaks English and Mandarin. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Ogilvie Syndrome, Retroperitoneal Inflammation, Gallbladder Disease, Bladder Reconstruction, and Endoscopy.

Stephen Swisher is a Thoracic Surgeon in Houston, Texas. Dr. Swisher is rated as an Elite provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Endoscopy, and Thymectomy.

Manoop Bhutani is a Gastroenterologist in Houston, Texas. Dr. Bhutani is rated as an Elite provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Esophageal Cancer, Pancreatic Cancer, Stomach Cancer, Endoscopy, and Colonoscopy.

Steven Lin is a Radiation Oncologist in Houston, Texas. Dr. Lin is rated as an Elite provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Lung Cancer, Esophageal Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Endoscopy.

Ritsuko Komaki is a Radiation Oncologist in Victoria, Texas. Dr. Komaki is rated as an Elite provider by MediFind in the treatment of Esophageal Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Esophageal Cancer.

Alan Kaye is a primary care provider, practicing in Internal Medicine in Dallas, Texas. Dr. Kaye is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Sitosterolemia, High Cholesterol, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Kimberly Washington is fellowship-trained in hepato-pancreato-biliary surgery with vast experience in the surgical and non-surgical treatment of liver, pancreas and biliary tract disorders. She uses a variety of techniques, including minimally invasive laparoscopy, endoscopy, ablation and robotic-assisted approaches, in the management of benign pancreatic masses, acute/chronic pancreatitis and pancreatic cysts. She is also trained in the management of hepatocellular carcinoma, cholangiocarcinoma and all liver metastatic diseases. Additionally, she treats benign diseases of the liver and biliary tract, including hepatic adenomas, liver hemangiomas, polycystic liver disease, simple and complex biliary stone disease, and bile duct injuries.Dr. Washington earned her medical degree and completed general surgery residency at the University of Tennessee in Memphis. She then served the Arlington, Texas community as a board-certified general surgeon from 2014 until 2020. In 2020, she returned to training in hepato-pancreato-biliary surgery fellowship at Oregon Health & Science University in Portland.In addition to her dedication to the management of surgical disease, Dr. Washington has also served on a global scale, caring for patients in India, Peru, Guatemala and Kenya. She has and continues to serve on numerous regional and national committees to advance the treatment of hepato-pancreato-biliary diseases. Dr Washington has published peer-reviewed works on areas of special interest, including multi-disciplinary management of colorectal liver metastasis with node-negative primary disease and surgical management of breast cancer liver metastasis, presenting many of these published works at national and international meetings. Through her role as a faculty member with the TCU Burnett School of Medicine, Dr. Washington was recognized in 2024 with the Gachman Endowed Faculty Excellence Award. She is a member of the American College of Surgeons, Americas Hepato-Pancreato-Biliary Association, American Pancreatic Association, Association of Women Surgeons, International Hepato-Pancreato-Biliary Association, Society of Surgical Oncology and Society for Surgery of the Alimentary Tract. Dr. Washington is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. Her top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatic Pseudocyst, Pancreatectomy, and Liver Embolization.

Tarek Sawas is an Internal Medicine specialist and a Gastroenterologist in Dallas, Texas. Dr. Sawas is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Barrett Esophagus, Cholangitis, Hereditary Pancreatitis, Endoscopy, and Gastric Bypass.

Dr. Tom Shires is a Fellow of the American College of Surgeons and sits on their Board of Governors. He specializes in hepatic, pancreatic and biliary surgery. He has followed in the footsteps of his surgeon father, who was a leading researcher and pioneer in the areas of trauma and burn care. Dr. Shires currently serves as the John P. Thompson Chair for Surgical Services at Texas Health Presbyterian Hospital Dallas and on the hospital's Board of Trustees. He also sits on numerous committees, including Texas Health Dallas' Medical Executive Committee and Surgical Services Committee.Dr. Shires graduated with honors from Duke University School of Medicine in Durham, N.C., and completed his general surgery residency training at Emory University School of Medicine in Atlanta, Ga. He was the Harvey Cushing Research Fellow at Cornell University Medical College New York Presbyterian Hospital and the Daniel Elkin Clinical Fellow at Emory.He has decades of experience in the use of advanced and minimally invasive surgical techniques. He previously served as Chief of Surgery at Zale-Lipshy University Hospital in Dallas and as Chairman of the GI and Endocrine Division at The University of Texas Southwestern Medical Center, also in Dallas. Dr. Shires is an avid lecturer, author, medical editor and medical reviewer. Dr. Shires' special interest in surgical education shows through in his role as the residency program director for surgery residents at Texas Health Dallas.Dr. Shires is an active member of such organizations as the North Texas Chapter of the American College of Surgeons, American Hepato Pancreato Biliary Association, The Society for Surgery of the Alimentary Tract, Surgical Infection Society and Association for Academic Surgery. Dr. Shires is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Insulinoma, Pancreatectomy, and Hernia Surgery.

Joe Chang is a Radiation Oncologist in Houston, Texas. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).

Dr. Kelly received his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship, residency and oncology fellowship from the Royal College of Physicians in Ireland in 2007. Dr. Kelly completed a second fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda MD from 2007–2009 and continued as a clinical researcher in thoracic oncology at the NCI until moving to Johns Hopkins in 2011. At Johns Hopkins, Dr. Kelly was the director of the gastroesophageal cancer therapeutics program and also served as the director of global oncology for Johns Hopkins International. Dr. Kelly was recruited as the Director of Oncology for the Charles A. Sammons Cancer Center and the Chief of Oncology for the North Texas Division of the BSWH system in 2018. Dr. Kelly performs translational and clinical research encompassing the discovery and the development of new targeted and immunotherapeutic approaches in the prevention and treatment of gastroesophageal cancer and lung cancer and he is the International principal investigator on a number of global phase II/III clinical trials in these disease areas. In addition he is leading efforts nationally and internationally to design quality metrics for solid tumors and implementing value-based algorithms to help bend the cost curve in the United States. At the Charles A. Sammons Cancer Center he also helps to co-lead the Innovative Clinical Trials Center which investigates novel therapeutics across a range of tumor types. He serves as the co-chair of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) taskforce working to improve the quality of care received by lung cancer patients worldwide. He is an active member of ASCO and the Eastern Cooperative Oncology group. He is a founding member of the International Quality Oncology Taskforce in ASCO and serves on the ASCO measures taskforce, the clinical practice committee and the lung cancer quality taskforce. He has authored and co-authored over 150 peer-reviewed publications, abstracts and book chapters, and contributed his work to many prominent healthcare journals. Dr. Kelly’s leadership of oncology services spans Baylor Scott & White’s footprint in the Dallas-Fort Worth area, which includes Baylor University Medical Center—the System’s North Texas flagship hospital and one of the largest cancer hospitals in the nation—as well as a network of 11 Baylor Charles A. Sammons Cancer Centers throughout Texas. Publications. Dr. Kelly is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Esophageal Cancer, Gastroesophageal Junction Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Tissue Biopsy.

Inderpal Sarkaria is a General Surgeon and a Thoracic Surgeon in Dallas, Texas. Dr. Sarkaria is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Esophageal Cancer, Hiatal Hernia, Lung Cancer, Thymectomy, and Endoscopy.

Reza Mehran is a Thoracic Surgeon and a General Surgeon in Houston, Texas. Dr. Mehran is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Hepato-Pancreato-Biliary Surgery.

Shanda Blackmon is a General Surgeon and a Surgical Oncologist in Houston, Texas. Dr. Blackmon is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. Her top areas of expertise are Achalasia, Lung Cancer, Mesothelioma, Endoscopy, and Thymectomy. Dr. Blackmon is currently accepting new patients.

Shawn S. Groth, M.D. is a board-certified general thoracic surgeon in Houston who specializes in minimally invasive thoracic surgery. After finishing his cardiothoracic surgery residency under Dr. David J. Sugarbaker at the Brigham and Women’s Hospital, Harvard Medical School, Dr. Groth pursued an advanced fellowship in minimally invasive esophageal surgery at the University of Pittsburgh under the mentorship of Dr. James D. Luketich, a pioneer in minimally invasive foregut surgery. Dr. Groth seeks to bring that expertise to Baylor. As part of a team effort with other health care providers, Dr. Groth’s practice includes the multi-disciplinary management of benign and malignant disorders of the esophagus/foregut, lung, pleural space, mediastinum, chest wall, and diaphragm. As the Director of Esophageal Surgical Services at Baylor St. Luke’s Medical Center, Dr. Groth will co-direct a newly created swallow center, which will provide a multi-disciplinary approach to managing patients with gastroesophageal reflux disease and esophageal motility disorders. He provides minimally invasive approaches to managing benign (e.g., gastroesophageal reflux disease, paraesophageal hernias, achalasia, benign strictures, and esophageal diverticuli) and malignant foregut disorders (e.g., malignant strictures and esophageal and gastroesophageal junction cancers), as well as Barrett’s esophagus. Already a well-published investigator, Dr. Groth has presented his work at numerous national society meetings, including The American College of Surgeons, The American College of Chest Physicians, The American Society of Clinical Oncology, The Society of Thoracic Surgeons, and The American Association for Thoracic Surgery. Dr. Groth’s clinical research focuses on thoracic oncology outcomes research, health care disparities research, and clinical trials. He has explored several topics directed towards improving the guideline treatment of cancer patients. His basic science and translational research efforts are directed towards advancing personalized oncology. In light of the COVID-19 pandemic, the Baylor College of Medicine General Thoracic Surgery Clinic is offering telemedicine clinic visits. To schedule, please call the main line at 713-798-6376. Dr. Groth is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Mesothelioma, Achalasia, Metastatic Pleural Tumor, Endoscopy, and Gastrostomy.

Salmaan Jawaid, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Salmaan Jawaid specializes in Gastroenterology and works at BCM Gastroenterology. To make an appointment, please call (713) 798-0950. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Jawaid is rated as an Advanced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Gastrointestinal Bleeding, Hereditary Pancreatitis, Achalasia, Endoscopy, and Colonoscopy.

Prajnan Das is a Radiation Oncologist in Houston, Texas. Dr. Das is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Stomach Cancer, Anal Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Endoscopy.

Jason Fleming is a Surgical Oncologist and a General Surgeon in Dallas, Texas. Dr. Fleming is rated as an Experienced provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Small Bowel Resection.

Brian Weston is a Gastroenterologist in Houston, Texas. Dr. Weston is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Jaundice, Esophageal Cancer, Stomach Cancer, Endoscopy, and Pancreaticoduodenectomy.

Jing Li is a Radiation Oncologist in Houston, Texas. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of Esophageal Cancer. Her top areas of expertise are Breast Cancer, Lung Cancer, Osteosarcoma, Endoscopy, and Percutaneous Coronary Intervention (PCI).